Comparison between an in-house SARS-CoV-2 ELISpot and the T-Spot® Discovery SARS-CoV-2 for the assessment of T cell responses in prior SARS-CoV-2-infected individuals

https://doi.org/10.1016/j.jcv.2022.105158Get rights and content

Cited by (0)

View Abstract